Login / Signup

Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia.

Andrea D'AlessioP Del PoggioF BracchiGiovanni Carlo CesanaN SertoriD Di MauroA FargnoliM MottaC GiussaniP MoroG VitaleM GiacominiG Borra
Published in: Leukemia (2020)
Keyphrases
  • sars cov
  • low dose
  • respiratory syndrome coronavirus
  • high dose
  • early onset
  • community acquired pneumonia
  • mechanical ventilation